ACR appropriateness criteria® retreatment of recurrent head and neck cancer after prior definitive radiation: Expert panel on radiation oncology-head and neck cancer

Mark W. McDonald, Joshua Lawson, Madhur K. Garg, Harry Quon, John A. Ridge, Nabil Saba, Joseph K. Salama, Richard V. Smith, Anamaria Reyna Yeung, Sue S. Yom, Jonathan J. Beitler

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Recurrent and second primary head-and-neck squamous cell carcinomas arising within or in close proximity to previously irradiated fields are a common clinical challenge. Whereas surgical salvage therapy is recommended for resectable disease, randomized data support the role of postoperative reirradiation in high-risk patients. Definitive reirradiation is an established approach for patients with recurrent disease who are medically or technically inoperable or decline radical surgery. The American College of Radiology Expert Panel on Head and Neck Cancer reviewed the relevant literature addressing re-treatment after prior definitive radiation and developed appropriateness criteria for representative clinical scenarios. Examples of unresectable recurrent disease and microscopic residual disease after salvage surgery were addressed. The panel evaluated the appropriateness of reirradiation, the integration of concurrent chemotherapy, radiation technique, treatment volume, dose, and fractionation. The panel emphasized the importance of patient selection and recommended evaluation and treatment at tertiary-care centers with a head-and-neck oncology team equipped with the resources and experience to manage the complexities and toxicities of re-treatment.

Original languageEnglish (US)
Pages (from-to)1292-1298
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume80
Issue number5
DOIs
StatePublished - Aug 1 2011

Fingerprint

Radiation Oncology
Retreatment
Head and Neck Neoplasms
cancer
Radiation
radiation
surgery
Dose Fractionation
Salvage Therapy
radiology
Therapeutics
chemotherapy
Radiology
Tertiary Care Centers
fractionation
toxicity
Patient Selection
proximity
therapy
resources

Keywords

  • Appropriateness criteria
  • Head-and-neck cancer
  • Reirradiation
  • Salvage therapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

ACR appropriateness criteria® retreatment of recurrent head and neck cancer after prior definitive radiation : Expert panel on radiation oncology-head and neck cancer. / McDonald, Mark W.; Lawson, Joshua; Garg, Madhur K.; Quon, Harry; Ridge, John A.; Saba, Nabil; Salama, Joseph K.; Smith, Richard V.; Yeung, Anamaria Reyna; Yom, Sue S.; Beitler, Jonathan J.

In: International Journal of Radiation Oncology Biology Physics, Vol. 80, No. 5, 01.08.2011, p. 1292-1298.

Research output: Contribution to journalArticle

McDonald, Mark W. ; Lawson, Joshua ; Garg, Madhur K. ; Quon, Harry ; Ridge, John A. ; Saba, Nabil ; Salama, Joseph K. ; Smith, Richard V. ; Yeung, Anamaria Reyna ; Yom, Sue S. ; Beitler, Jonathan J. / ACR appropriateness criteria® retreatment of recurrent head and neck cancer after prior definitive radiation : Expert panel on radiation oncology-head and neck cancer. In: International Journal of Radiation Oncology Biology Physics. 2011 ; Vol. 80, No. 5. pp. 1292-1298.
@article{efab2c7ddff048018799d312ea6f629c,
title = "ACR appropriateness criteria{\circledR} retreatment of recurrent head and neck cancer after prior definitive radiation: Expert panel on radiation oncology-head and neck cancer",
abstract = "Recurrent and second primary head-and-neck squamous cell carcinomas arising within or in close proximity to previously irradiated fields are a common clinical challenge. Whereas surgical salvage therapy is recommended for resectable disease, randomized data support the role of postoperative reirradiation in high-risk patients. Definitive reirradiation is an established approach for patients with recurrent disease who are medically or technically inoperable or decline radical surgery. The American College of Radiology Expert Panel on Head and Neck Cancer reviewed the relevant literature addressing re-treatment after prior definitive radiation and developed appropriateness criteria for representative clinical scenarios. Examples of unresectable recurrent disease and microscopic residual disease after salvage surgery were addressed. The panel evaluated the appropriateness of reirradiation, the integration of concurrent chemotherapy, radiation technique, treatment volume, dose, and fractionation. The panel emphasized the importance of patient selection and recommended evaluation and treatment at tertiary-care centers with a head-and-neck oncology team equipped with the resources and experience to manage the complexities and toxicities of re-treatment.",
keywords = "Appropriateness criteria, Head-and-neck cancer, Reirradiation, Salvage therapy",
author = "McDonald, {Mark W.} and Joshua Lawson and Garg, {Madhur K.} and Harry Quon and Ridge, {John A.} and Nabil Saba and Salama, {Joseph K.} and Smith, {Richard V.} and Yeung, {Anamaria Reyna} and Yom, {Sue S.} and Beitler, {Jonathan J.}",
year = "2011",
month = "8",
day = "1",
doi = "10.1016/j.ijrobp.2011.02.014",
language = "English (US)",
volume = "80",
pages = "1292--1298",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - ACR appropriateness criteria® retreatment of recurrent head and neck cancer after prior definitive radiation

T2 - Expert panel on radiation oncology-head and neck cancer

AU - McDonald, Mark W.

AU - Lawson, Joshua

AU - Garg, Madhur K.

AU - Quon, Harry

AU - Ridge, John A.

AU - Saba, Nabil

AU - Salama, Joseph K.

AU - Smith, Richard V.

AU - Yeung, Anamaria Reyna

AU - Yom, Sue S.

AU - Beitler, Jonathan J.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Recurrent and second primary head-and-neck squamous cell carcinomas arising within or in close proximity to previously irradiated fields are a common clinical challenge. Whereas surgical salvage therapy is recommended for resectable disease, randomized data support the role of postoperative reirradiation in high-risk patients. Definitive reirradiation is an established approach for patients with recurrent disease who are medically or technically inoperable or decline radical surgery. The American College of Radiology Expert Panel on Head and Neck Cancer reviewed the relevant literature addressing re-treatment after prior definitive radiation and developed appropriateness criteria for representative clinical scenarios. Examples of unresectable recurrent disease and microscopic residual disease after salvage surgery were addressed. The panel evaluated the appropriateness of reirradiation, the integration of concurrent chemotherapy, radiation technique, treatment volume, dose, and fractionation. The panel emphasized the importance of patient selection and recommended evaluation and treatment at tertiary-care centers with a head-and-neck oncology team equipped with the resources and experience to manage the complexities and toxicities of re-treatment.

AB - Recurrent and second primary head-and-neck squamous cell carcinomas arising within or in close proximity to previously irradiated fields are a common clinical challenge. Whereas surgical salvage therapy is recommended for resectable disease, randomized data support the role of postoperative reirradiation in high-risk patients. Definitive reirradiation is an established approach for patients with recurrent disease who are medically or technically inoperable or decline radical surgery. The American College of Radiology Expert Panel on Head and Neck Cancer reviewed the relevant literature addressing re-treatment after prior definitive radiation and developed appropriateness criteria for representative clinical scenarios. Examples of unresectable recurrent disease and microscopic residual disease after salvage surgery were addressed. The panel evaluated the appropriateness of reirradiation, the integration of concurrent chemotherapy, radiation technique, treatment volume, dose, and fractionation. The panel emphasized the importance of patient selection and recommended evaluation and treatment at tertiary-care centers with a head-and-neck oncology team equipped with the resources and experience to manage the complexities and toxicities of re-treatment.

KW - Appropriateness criteria

KW - Head-and-neck cancer

KW - Reirradiation

KW - Salvage therapy

UR - http://www.scopus.com/inward/record.url?scp=79960075718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960075718&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2011.02.014

DO - 10.1016/j.ijrobp.2011.02.014

M3 - Article

C2 - 21530100

AN - SCOPUS:79960075718

VL - 80

SP - 1292

EP - 1298

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 5

ER -